BT
BlackTensor
HomeAboutServicesSolutionsCase Studies
Contact

BlackTensorAI

Building the future of intelligent systems with cutting-edge AI solutions.

Navigate

  • Home
  • About
  • Services
  • Solutions
  • Case Studies
  • Contact

Services

  • AI Development
  • Cloud Infrastructure
  • Data Engineering
  • Consulting

Get in Touch

  • hello@blacktensorai.com
  • Islamabad, PK

© 2026 BlackTensorAI. All rights reserved.

Built with precision and purpose.

R&D Case Study — Agentic AI for Drug Safety

SafeSignal AI — Human-Governed Pharmacovigilance Automation

A multi-agent pharmacovigilance workflow that transforms unstructured adverse-event information into traceable, reviewer-ready safety cases with duplicate detection and E2B(R3)-aligned output.

R&D prototype evaluated on synthetic safety reports. This is not a production medical device, clinical decision system, or autonomous regulatory-submission tool.

Build Something Like This
SafeSignal AI — Human-Governed Pharmacovigilance Automation

The Challenge

Drug-safety reports arrive through fragmented channels and require careful validity checks, seriousness triage, duplicate detection, terminology mapping, and evidence-backed narratives. General-purpose automation can accelerate the work but may omit critical facts or invent missing information, making traceability and human control essential.

What We Built

  • Specialist LangGraph agents for intake, validity checks, clinical extraction, seriousness triage, duplicate detection, narrative drafting, and quality review
  • Field-level provenance linking every extracted value and narrative statement to its original evidence
  • Hybrid controls combining language models with deterministic validation, confidence thresholds, and mandatory human approval
  • Temporal case graph and E2B(R3)-aligned structured output for reviewer-ready safety operations
LangGraphFastAPIPostgreSQLpgvectorNeo4jn8nOCRWhisperReactDockerOpenTelemetry

Synthetic Prototype Benchmark

Serious-event detection recall

96.2% on 180 held-out synthetic cases

First-pass preparation time

18 min manual → 3.4 min assisted

Reviewer correction rate

11.8% across 1,260 extracted fields

Results are illustrative figures from a controlled synthetic-data prototype evaluation. They are not independently validated production results and do not represent performance in a live pharmacovigilance operation. Human approval remains required before export or downstream action.

More Work

Batch Disclosure — Price-Moving Catalyst Detection

Batch Disclosure — Price-Moving Catalyst Detection

An AI-powered system that scans ASX and SEC filings for forward-looking disclosures — contracts, M&A, guidance — that move micro-cap prices before the market catches on.

WikiGen — Autonomous, Bias-Aware Knowledge Synthesis

WikiGen — Autonomous, Bias-Aware Knowledge Synthesis

A multi-agent GraphRAG system that autonomously writes reliable, bias-aware Wikipedia-style articles with verifiable provenance on every claim.

Let's Work Together

Explore a Safer AI Workflow?

Start with a bounded, synthetic-data pilot and a jointly defined validation plan.

Start a Project